Galactose-1-phosphate is a regulator of inositol monophosphatase: A fact or a fiction?

Medical Hypotheses

Volumn 60, Issue 1, 2003, Pages 123-128

  Bhat, Paike Jayadeva ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; INOSITOL PHOSPHATE; NEUROTRANSMITTER; TRIPHOSPHOINOSITIDE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN; CONTROLLED STUDY; DIET; ENZYME DEFICIENCY; ENZYME REGULATION; FEEDING DISORDER; GALACTOSEMIA; GROWTH RETARDATION; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INFANT; JAUNDICE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OVARY INSUFFICIENCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPTOM;

EID: 0037220097     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00347-X     Document Type: Article

References (37)

1. Segal S., Berry G. Disorders of galactose metabolism. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (eds). The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1995: 976-1000.
2. Petry K. G., Reichardt K. K. V. The fundamental importance of human galactose metabolism: Lessons from genetics and biochemistry. Trends Genet 1998; 14: 98-102.
3. Segal S. Galactosemia today: The enigma and the challenge. J Inher Metab Dis 1998; 21: 455-471.
4. Hohon J. B., Walter J. H., Tyfield L. A. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (eds). The Metabolic and Molecular Basis of Inherited Diseases, 8th Edn. New York: McGraw-Hill, 2001: 453-480.
5. Mehta D. V., Kabir A., Bhat P. J. Expression of human inositol monophosphatase suppresses galactose toxicity in Saccharomyces cerevisiae: Possible implications in galactosemia. Biochem Biophys Acta 1999; 1454: 217-226.
6. Lai K., Elsas L. J. Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase deficient yeast. Biochem Biophys Res Commun 2000; 271: 392-400.
7. Berry G. T., Nissim I., Lin Z., Mazur A. T., Gibson J. B., Segal S. Endogenous synthesis of galactose in normal man and patients with heriditary galactosemia. Lancet 1995; 346: 1073-1074.
8. Segal S. In utero galactose intoxication on animals. Eur J Pediatr 1995; 154(suppl. 2): S82-S86.
9. Holton J. B. Effects of galactosemia in utero. Eur J Pediatr 1995; 154(suppl. 2): S77-S81.
10. Gitzelman R., Steinmann B. Galactosemia: How does long-term treatment change the outcome? Enzyme 1994; 32: 37-46.
11. Gitzelman R. Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr 1995; 154(suppl. 2): S45-S49.
12. Segal S. Galactosemia unsolved. Eur J Pediatr 1997; 154(suppl. 2): S97-S102.
13. Berry G. The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr 1995; 154(suppl. 2): S53-S64.
14. Quan-Ma R., Wells H. J., Wells W. W., Shernan F. E., Egan T. J. Galactitol in the tissue of a galactosemic child. Am J Dis Child 1996; 112: 477-478.
15. Wells W. W., Pitman T. A., Wells H. J., Egan T. J. The isolation and identification of galactitol from the brains of galactosemic patients. J Biol Chem 1965; 240: 1002-1004.
16. Wells H. J., Wells W. W. Galactose toxicity and myoinositol metabolism in the developing rat brain. Biochem J 1967; 6: 1168-1173.
17. Stewart M. A., Kurian M. M., Sherman W. R., Cotlier E. V. Inositol changes in nerve and lense of galactose fed rats. J Neurochem 1968; 15: 941-946.
18. Warfield A. S., Segal S. Myo-inositol and phosphotidylinositol metabolism in synaptosomes from galactose fed rats. Proc Natl Acad Sci USA 1978; 75: 4568-4572.
19. 31P magnetic resonance spectroscopy. Eur J Pediatr 1995; 54(suppl. 2): S8-S13.
20. Sigal S. H., Yandrasitz J. R., Berry G. T. Kinetic model for a compartmentalization of myoinositol in hepatocytes. Metabolism 1993; 42: 395-401.
21. +)-ATP induced inhibition in aortic wall of rabbits. Diabatalogia 1989; 32: 402-408.
22. Parthasarathy R., Parthasarathy L., Vandal R. Brain inositol monophosphatase identified as a galactose-1-phosphatase. Brain Res 1997; 778: 99-106.
23. Ostergaard S., Olson L., Nielsen In vivo dynamics of galactose metabolism in Saccharomyces cerevisiae: Metabolic fluxes and metabolite levels. J Biotech Bioeng 2001; 73: 412-425.
24. Daran J. M., Dallies N., Thines-sempoux D., Paquet V., Francois J. Genetic and biochemical regulation of the UGP 1 gene encoding the UDP-glucose pyrophosphorylase from Saccharomyces cerevisiae. Eur J Biochem 1995; 233: 520-530.
25. Berry G. T., Nissim I., Gobson J. B., Mazur A. T., Lin Z., Elsas L. J., Singh R. H., Klein P. D., Segal S. Quantitative assessment of whole body galactose metabolism in galactosemic patients. Eur J Pediatr 1997; 156(suppl. 1): S43-S49.
26. Gulavita S. J., Zang L., Dougherty J. J., Dain J. A. Galactose-1-phosphatase in rat brain. J Neurochem 1991; 57: 520-526.
27. Leslie N. D., Lager K. I., McNamara P. D., Segal S. A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med 1996; 59: 7-12.
28. Belmarker R. H., Livne A., Agam G. The role of inositol monophosphate inhibition in the mechanism of action of Lithium. Acta Pharmacol Toxicol 1990; 66(suppl.): 76-83.
29. Pacheco M. A., Jope R. S. Phosphoinositide signaling in human brain. Prog Neurobiol 1996; 50: 255-273.
30. Soares J. C., Mallingre A. G. Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients. Psychopharmacol Bull 1997; 33: 685-691.
31. Berridge M., Downes C. P., Hanley M. R. Neural and developmental actions of lithium: A unifying hypothesis. Cell 1989; 59: 411-419.
32. Milien G. E., Malteaux J. M., Seghers A., Charles G. Lithium therapy in the treatment of manic-depressive illness. Arch Int Pharmacodynammie Therapie 1995; 330: 251-278.
33. Sjoholt G., Molven A., Lovlie R., Wilcox A., Sikea J. M., Steen V. M. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA). Genomics 1997; 45:113-122.
34. Yoshikawa T., Turner G., Esterling L. E., Sanders A. R., Deterawadleigh S. D. A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder. Mol Psychol 1997; 2: 393-397.
35. Yoshikawa T., Sanders A. R., Esterling L. E., Overhauser J., Garnes J. A., Lennon G., Grewal R., Deterawadleigh S. D. Isolation of chromosome 18-specific brain transcripts as positional candidates for Bipolar disorder. Am. J Med Genet 1997; 74: 140.
36. Masuda C. A., Xavier M. A., Mattos K. A., Galina A., Montero-Lomeli M. Phosphoglucomutase is an in vivo lithium target in yeast. J Biol Chem 2001; 276: 37794-37801.
37. Philibert R. A., Egeland J. A., Paul S. A., Genns E. I. The inheritance of bipolar affective disorder: Abundant genes coming together. J Affect Disord 1997; 43: 1-3.